Answers are grounded in this paper and cite their sources.
Spinal muscular atrophy (SMA) results from degeneration of spinal anterior horn cells, leading to muscle weakness and atrophy.The most common form, 5q-SMA, is caused by mutations in the SMN1 gene on chromosome 5q.Other forms of SMA are non-5q-SMA resulting from various genetic abnormalities.One is spinal muscular atrophy with lower extremity predominance (SMALED), which is usually autosomal dominant and affects the lower extremities; SMALED1 results from a DYNC1H1 mutation; SMALED2 from a BICD2 mutation [1].Here, we describe the peri-operative management of an infant with de novo SMALED2B and highlight the key considerations of prolonged neuromuscular blockade and its monitoring and reversal.The B variant of SMALED2 is a severe form with prenatal onset, respiratory failure, and arthrogryposis multiplex congenita (AMC), which is known to occur more frequently in de novo cases than in inherited cases [2].Patients with SMA have increased sensitivity to non-depolarising neuromuscular blocking agents, likely due to reduced acetylcholine concentrations at the neuromuscular junction [3].Careful neuromuscular blockade management is therefore vital to prevent residual paralysis.An 85-day-old male infant who was reliant on high-flow nasal oxygenation for respiratory failure and had multiple joint contractures underwent percutaneous Achilles tenotomy and pinning for bilateral talipes valgus, as well as rigid bronchoscopy and tracheostomy for bilateral vocal cord paralysis.We anticipated difficult tracheal intubation due to micrognathia and limited neck mobility secondary to AMC.Appropriate equipment including video laryngoscopes was prepared.Tracheal intubation was smoothly accomplished with an Airway Scopeâ (Nihon Kohden Corporation, Tokyo, Japan) on the first attempt.Anaesthesia was induced and maintained with sevoflurane and remifentanil.After baseline train-of-four monitoring was established using a TOF-Watch SXâ (Organon, Dublin, Ireland) at the adductor pollicis muscle, an initial dose of rocuronium 0.6 mg.kg À1 was administered intravenously.While the adductor pollicis may not precisely reflect the blockade of upper airway muscles, which are often affected in SMA, we considered it an appropriate monitoring site in this case because SMALED2B spares upper extremity strength and reflexes [1].Recovery of the third twitch on the train-of-four count took 102 min; the fourth twitch recovered at 121 min, with the return of spontaneous respiration at 132 min.As expected, the patient showed increased sensitivity to rocuronium, similar to that encountered in classical SMA.In healthy infants aged 2-4 months undergoing general anaesthesia, the time to recovery of a train-of-four ratio of 0.7 has been reported as 63.8 Æ 14 min after administration of rocuronium 0.6 mg.kg À1 [4].At the completion of the surgery, 2 mg.kgÀ1 of sugammadex was administered to reverse the prolonged rocuroniuminduced paralysis, which facilitated smooth emergence from anaesthesia.
No takes yet. Share an insight, caveat, or question.
Shimazu et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: